Harbour BioMed
Harbour BioMed is a global, clinical-stage biopharmaceutical company developing innovative therapeutics in the fields of immuno-oncology and inflammatory diseases. Harbour BioMed was founded in 2016 and is headquartered in Massachusetts.
Last updated on
About Harbour BioMed
Founded
2016Estimated Revenue
$10M-$50MEmployees
51-250Funding / Mkt. Cap
$178MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
2834NAICs Code
32541Location
City
CambridgeState
MassachusettsCountry
United StatesTech Stack (24)
